Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

Adrian PencakPharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak.

Pencak joins the German consultancy group following over 25 years’ global business development, marketing and operations experience, spanning the life sciences and healthcare sectors.

He said: “I am very excited to have joined the PharmaLex management team as we are a company with ambitious growth targets as well as extremely high standards of services.

“I’m looking forward to playing a key role in our continued growth and success, with a special focus on the US.”

He joins the group from ICON, where he was vice president, global business development early phase services.

Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s appointment demonstrates our commitment to developing our global infrastructure and sales.

“Alongside his strong business development experience, Adrian’s background in the IT space will also support our artificial intelligence and innovative led services.”

24th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...
Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...

Infographics